Sarepta Therapeutics diskutieren
Sarepta Therapeutics
WKN: A1J1BH / Symbol: AVII / Name: Sarepta / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
113,50 €
-2,28 %
Sarepta Therapeutics
SecteurRecherche biotechnologique et médicale Agenda 08/11 Publication de résultats
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases.
It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates.
The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
Nombre d'employés : 255 personnes.
(Stop Loss Kurs erreicht)
(Vom Mitglied beendet)
SecteurRecherche biotechnologique et médicale Agenda 28/02 Publication de résultats
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases.
It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates.
The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
Nombre d'employés : 255 personnes.
Sell Sarepta Therapeutics
Buy mit Kursziel 100,0
Buy mit Kursziel 160,0
Buy Sarepta Therapeutics
Buy mit Kursziel 168,0
Buy mit Kursziel 75,0
Buy Sarepta Therapeutics
Buy mit Kursziel 100,0
Sell Sarepta Therapeutics
Buy Sarepta Therapeutics
Neueste Beiträge
Traumtanz in Commerzbank AG diskutieren